Arena Pharmaceuticals, Inc.

Good day and thank you for standing by and welcome to the ARENA Pharmaceuticals 3rd Quarter 2021 Update Conference Call. At this time, all participants are on a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 1 on your telephone or touchtone key. If you require an operator assistance, please press star 0. I would now like to hand the conference over to your first speaker today, Vice President of Investor Relations and Corporate Communications, Patrick Malloy. Thank you. Please go ahead, sir.

Great. Thank you, Nika. Good afternoon, everyone. Thank you for joining us today. We'll get a chance to review the press release we issued this afternoon announcing our Q3 2021 financial results and key program updates. Joining me today on the call are Amit Munshi, our President and Chief Executive Officer, along with Lori Stelzer, our Executive Vice President and Chief Financial Officer. With regards to the format for today's call, in just a few moments, I'll hand the call over to Amit, who will make some opening comments, and then we will open up the call to a Q&A session. Before we begin, I would like to remind you that we'll be making some forward-looking statements today that involve risks and uncertainties about our goals, expectations, plans, beliefs, timing of events or future results, including those risks and uncertainties related to our pipeline, financial projections, and the COVID-19 pandemic. Forward-looking statements involve certain assumptions, risks, some of which may be beyond our control. All forward-looking statements are based on information currently available to ARENA, and we disclaim any obligation to update these forward-looking statements. A full description of these risks can be found on in our earnings press release and our latest SEC disclosure documents. Now, I'd like to turn the call over to Amit Munshi. Amit?

Thanks, Pat, and I hope everyone's got a chance to review the press release, and thanks for everyone being on the call today. So, let's jump right into Q&A. Okay.